HADLIMA™ (adalimumab-bwwd) | Official Patient Web Site
Discover how you can treat specific autoimmune and autoimflammatory conditions with HADLIMA™ (adalimumab-bwwd), an FDA-approved biosimilar of HUMIRA (adalimumab). Medication Guide Instructions for Use Prescribing Information
Dosing and Administration for HADLIMA™ (adalimumab-bwwd)
To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults. Review dosing and administration options for HADLIMA™ (adalimumab-bwwd) and watch a video with step-by-step injection instructions.
What is HADLIMA™ (adalimumab-bwwd) | Biosimilar Medications
To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adults. Learn more about HADLIMA™ (adalimumab-bwwd), which is an FDA-approved biosimilar to HUMIRA (adalimumab), and discover what HADLIMA is used to treat and how it may help you.
HADLIMA™ For You - Dedicated Patient Support & Savings
Injection guidance. We provide self-injection guidance to ensure you are well equipped with the knowledge and skills necessary to use either device for HADLIMA. To see how to use the HADLIMA™ PushTouch™ Autoinjector, scroll down to …
The HADLIMATM PushTouchTM Autoinjector has an audible start-stop click feature and a large medication window so you can see and hear when your full dose is complete. Learn more about the buttonless HADLIMA
Enroll in Co-Pay Assistance and Support for HADLIMA™ …
Find co-pay assistance for HADLIMA™ (adalimumab-bwwd). Enroll now to receive personalized support and ways to save on your prescription for HADLIMA. Medication Guide Instructions for Use Prescribing Information
HADLIMA For You provides injection support for self-administration. The comprehensive injection video shows the process of using the HADLIMA™ PushTouch™ Autoinjector. Injection Support To help with self-administering HADLIMA, scan to watch the patient injection video. IMPORTANT SAFETY INFORMATION (continued)
Site Map for HADLIMA™ (adalimumab-bwwd)
To treat non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye) in adult patients. Review the Site Map for HADLIMA™ (adalimumab-bwwd).